Peri- and postoperative haematologic management in a patient with type 2 von Willebrand disease undergoing mitral valve replacement.
Arnason
J E
JE
Mallik
A
A
De Sancho
M
M
D005169:Factor VIII / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000601:surgery*; D059035:Perioperative Period; D011182:Postoperative Care; D016896:Treatment Outcome; D056728:von Willebrand Disease, Type 2 / Q000188:drug therapy / Q000601:surgery*; D014841:von Willebrand Factor / Q000378:metabolism
D014841:von Willebrand Factor; C078147:F8 protein, human; D005169:Factor VIII